Home › NRBO
Neurobo Pharmaceuticals (NRBO) Stock Discussions on Social Media
About Neurobo Pharmaceuticals
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative and cardiometabolic diseases. Its therapeutics programs include NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of protein; and Gemcabene, which is focused on developing and commercializing therapies for the treatment of dyslipidemia. NeuroBo Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Boston, Massachusetts.
Real-Time Dow Stock List Congresswoman Nancy Pelosi Stock Tracker Top 100 popular stocks on Robinhood
Cap: | Volume (24h):